Waypoint Wealth Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Waypoint Wealth Counsel's LLY Position: Q2 2026 in Review
Waypoint Wealth Counsel reduced its Eli Lilly (LLY) stake by 30% in Q2 2026, selling an estimated $143K and leaving 324 shares worth $389K. The position accounts for 0.24% of the portfolio, ranked #70.
Waypoint Wealth Counsel first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $836K in Q4 2025. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Waypoint Wealth Counsel held 324 shares of Eli Lilly worth $389K as of Q2 2026.
- Waypoint Wealth Counsel sold 140 Eli Lilly shares in Q2 2026, an estimated $143K.
- Eli Lilly made up 0.24% of Waypoint Wealth Counsel's portfolio in Q2 2026, its #70 holding.
- Waypoint Wealth Counsel first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
- Waypoint Wealth Counsel's Eli Lilly position peaked at $836K in Q4 2025.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Waypoint Wealth Counsel's 13F filing for Q2 2026, filed 4 Aug 2026.